79 related articles for article (PubMed ID: 3094264)
1. [Kinetics of the antibody level in schistosomiasis under chemotherapy].
Schlisio W; Ziegler K
Z Gesamte Inn Med; 1986 Aug; 41(15):422-7. PubMed ID: 3094264
[TBL] [Abstract][Full Text] [Related]
2. [Immunofluorescence serologic findings in schistosomiasis. Methodologic aspects].
Schlisio W; Möller FW; Ziegler K
Z Gesamte Inn Med; 1989 Mar; 44(5):149-52. PubMed ID: 2496532
[TBL] [Abstract][Full Text] [Related]
3. Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren.
Creasey AM; Taylor P; Thomas JE
Cent Afr J Med; 1986 Jul; 32(7):165-7. PubMed ID: 3107836
[No Abstract] [Full Text] [Related]
4. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness and tolerance of praziquantel in schistosomiasis].
Groning E; Bakathir H; Salem A; Albert L; Fernández R
Rev Cubana Med Trop; 1985; 37(2):215-9. PubMed ID: 3938555
[No Abstract] [Full Text] [Related]
6. Praziquantel compared to niridazole in schistosomiasis intercalatum therapy.
Feldmeier H; Zwingenberger K; Steiner A; Dietrich M
Tropenmed Parasitol; 1981 Mar; 32(1):39-42. PubMed ID: 7233551
[TBL] [Abstract][Full Text] [Related]
7. Study of some aspects of cell mediated immune response in bilharzial children on a field level.
el-Hawey AM; Massoud AM; el-Rakieby A; Royzeik MS; Nassar MO
J Egypt Soc Parasitol; 1991 Aug; 21(2):411-6. PubMed ID: 1908498
[TBL] [Abstract][Full Text] [Related]
8. Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia.
Wilkins HA; Moore PJ
J Trop Med Hyg; 1987 Apr; 90(2):83-92. PubMed ID: 3104624
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of praziquantel efficiency in the treatment of schistosomiasis.
Khalil HM; el-Hawey AM; Abdel Baki MH; el-Hadi HM; Sharara MO
J Egypt Soc Parasitol; 1986 Dec; 16(2):403-12. PubMed ID: 3097166
[No Abstract] [Full Text] [Related]
10. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
[TBL] [Abstract][Full Text] [Related]
11. Schistosomiasis prevalence after administration of praziquantel to school children in Melela village, Morogoro region, Tanzania.
Kitange HM; Swai AB; McLarty DG; Alberti KG
East Afr Med J; 1993 Dec; 70(12):782-6. PubMed ID: 8026352
[TBL] [Abstract][Full Text] [Related]
12. Praziquantel in treatment of S. mansoni and S. haematobium infections.
Ahmed TH; Ali AA; Bassiouni GA; Omer SH; Shalaby MA
J Egypt Soc Parasitol; 1988 Jun; 18(1):313-24. PubMed ID: 3131447
[No Abstract] [Full Text] [Related]
13. Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area.
Midzi N; Ndhlovu PD; Nyanga L; Kjetland EF; Reimert CM; Vennervald BJ; Gomo E; Mudenge G; Friis H; Gundersen SG; Mduluza T
Parasite Immunol; 2003; 25(11-12):581-8. PubMed ID: 15053779
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of praziquantel in Egyptian schistosomiasis.
Ismail MM; Bruce JI; Attia MM; el-Ridi AM; Shabayek HA; Salama MM
J Egypt Soc Parasitol; 1986 Jun; 16(1):259-67. PubMed ID: 3088142
[No Abstract] [Full Text] [Related]
15. Performance of IgG avidity in an area endemic for schistosomiasis in Egypt.
Abou-Basha LM; Shehab AY; Abdel-Fattah M; Bassili A
East Mediterr Health J; 2002 Jan; 8(1):172-80. PubMed ID: 15330573
[TBL] [Abstract][Full Text] [Related]
16. Immune response in chronic Schistosomiasis haematobium and mansoni. Reversibility of alterations after anti-parasitic treatment with praziquantel.
Feldmeier H; Gastl GA; Poggensee U; Daffalla AA; Nogueira-Queiroz JA; Capron A; Peter HH
Scand J Immunol; 1988 Aug; 28(2):147-55. PubMed ID: 3137653
[TBL] [Abstract][Full Text] [Related]
17. [Schistosomiasis at Marselisborg hospital 1981-1990].
Tarp BD; Andersen PL
Ugeskr Laeger; 1996 Feb; 158(7):911-4. PubMed ID: 8638328
[TBL] [Abstract][Full Text] [Related]
18. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].
Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP
Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149
[TBL] [Abstract][Full Text] [Related]
19. [A ten-year follow-up observation on serum antibody level in schistosomiasis patients treated with praziquantel].
Xu S; Xia Z; Zhan F; Xu L
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):142-4. PubMed ID: 7554166
[TBL] [Abstract][Full Text] [Related]
20. Effect of early treatment with praziquantel on serum connective tissue metabolite markers in children and adolescents with intestinal schistosomiasis mansoni.
Hassanein HI; Zoheiry MM; Voss B; el Attar GM; Hassan SI; Demerdash ZA; el Baz HM; Yousif OA
Arzneimittelforschung; 1997 Jan; 47(1):84-7. PubMed ID: 9037450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
